Skip to main content

Find Clinical Trials

Home
Conditions
Neuroblastoma

Clinical trial condition

Neuroblastoma

Explore clinical trials studying Neuroblastoma. Study availability and eligibility vary by location and protocol.

355 public trials 67 recruiting studies

Refine in advanced search Browse all conditions

Neuroblastoma trial results

Recruiting

NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial

NCT06450041

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +7 more
Locations: Children's Hospital Los Angeles Los Angeles, California, United States

UCSF Benioff Children's Hospital San Francisco, California, United States

Children's Hospital Colorado Aurora, Colorado, United States

Comer Children's Hospital, University of Chicago Chicago, Illinois, United States

View all 13 locations

View Trial Details

Recruiting

Feasibility Study of Prolonged Administration of Naxitamab, Irinotecan, and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma

NCT07027748

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +10 more
Locations: Boston Children's Hospital Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Recruiting

Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation

NCT06942039

Conditions: Atypical Teratoid Rhabdoid Tumor, Brain Diseases, Brain Neoplasms, +38 more
Locations: Alberta Children's Hospital Calgary, Alberta, Canada

BC Children's Hospital Vancouver, British Columbia, Canada

CancerCare Manitoba (CCMB) Winnipeg, Manitoba, Canada

IWK Health Centre Halifax, Nova Scotia, Canada

View Trial Details

Recruiting

Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors

NCT06625190

Conditions: Alveolar Soft Part Sarcoma, Chordoma, Clear Cell Sarcoma, +51 more
Locations: University of Florida Gainesville, Florida, United States

View Trial Details

Recruiting

Familial Investigations of Childhood Cancer Predisposition

NCT03050268

Conditions: AML, Abnormalities, Multiple, Acute Leukemia, +206 more
Locations: St. Jude Children's Research Hospital Memphis, Tennessee, United States

View Trial Details

Recruiting

Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma

NCT00107289

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +10 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Recruiting

68Ga-DOTATATE Neuroblastoma Imaging Pilot

NCT04559217

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +7 more
Locations: McGill University Health Center - Children's hospital Montreal, Quebec, Canada

CHU Ste-Justine Montreal, Quebec, Canada

CIUSSS de l'Estrie-CHUS Hospital Sherbrooke, Quebec, Canada

View Trial Details

Recruiting

B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)

NCT04897321

Conditions: Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, Adrenal Gland Diseases, +65 more
Locations: St. Jude Children's Research Hospital Memphis, Tennessee, United States

View Trial Details

Recruiting

Phase I Study of Becotatug Vedotin for Safety and Efficacy in EGFR-Positive Pediatric Relapsed/Refractory or Metastatic Solid Tumors

NCT07584499

Conditions: Atypical Teratoid/Rhabdoid Tumors, Carcinoma, Carcinoma, Squamous Cell, +53 more
Locations: Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China

View Trial Details

Recruiting

Autologous B7-H3 Chimeric Antigen Receptor T Cells in Relapsed/Refractory Solid Tumors

NCT06500819

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Bone Tissue, +12 more
Locations: Stanford University Palo Alto, California, United States

View Trial Details